Real-World Pharmacovigilance Insights Into Drug-Induced Risk of Alopecia

November 2025 in “ Frontiers in Pharmacology ”

Huixiang Li, Haijian Wei, Qiaoqiao Shentu, Jianxin Cui, Jiaojiao Chen

alopecia drug-induced alopecia pharmacovigilance clinical vigilance

Studysummary This pharmacovigilance study identified 64 drugs linked to hair loss, revealing specific demographic trends and timing patterns, and emphasized the importance of gender-specific monitoring and label updates to better convey real-world risks. Our plain-language summary of this paper — not a Tressless recommendation.

This large-scale pharmacovigilance study identified 64 drugs associated with significant alopecia signals, revealing distinct demographic patterns and latency periods. The study emphasizes the importance of increased clinical vigilance, gender-specific monitoring, and updates to drug labels to more accurately represent real-world risks of alopecia.

View this study on public-pages-files-2025.frontiersin.org →

Discuss this study in the Community →

Research cited in this study

29 / 29 results

research Alopecia in Children with Cancer: A Review from Pathophysiology to Management

1 citations , June 2025 in “American Journal of Clinical Dermatology”

Scalp cooling and minoxidil can help manage hair loss in children with cancer, but more research is needed.

research Recent Advances in Drug Development for Hair Loss

April 2025 in “International Journal of Molecular Sciences”

This review highlights the limitations of existing hair loss treatments like minoxidil and finasteride and suggests that future therapies may benefit from focusing on antibody and cell-based treatments, which offer targeted and potentially transformative options for managing hair loss disorders.

research Epidemiological Landscape of Androgenetic Alopecia in the US: An All of Us Cross-Sectional Study

February 2025 in “PLoS ONE”

This study provides an overview of androgenetic alopecia in the USA, highlighting social determinants, differences in onset between genders, and how management varies by age and gender.

research Chemotherapy-Induced Alopecia by Docetaxel: Prevalence, Treatment, and Prevention

September 2024 in “Current Oncology”

This review discusses the common occurrence of docetaxel-induced hair loss in cancer patients, including permanent cases, and highlights current and experimental strategies like scalp cooling, minoxidil, and new clinical trials for managing and preventing this side effect.

research Drug-Induced Hair Loss: Analysis of the Food and Drug Administration’s Adverse Events Reporting System Database

July 2024 in “Skin Appendage Disorders”

This study analyzed adverse event reports from the FDA database and found that drugs such as immunomodulatory agents, monoclonal antibodies, minoxidil, contraceptives, and anti-TNF drugs are frequently associated with hair loss, suggesting guidance for dermatologists in identifying common medications linked to alopecia.

research A Cross-Sectional Analysis of Medications Used by Patients Reporting Alopecia Areata on the FDA Adverse Events Reporting System

6 citations , January 2024 in “International Journal of Dermatology”

This study examined FAERS data and found an increasing trend in alopecia areata cases, with monoclonal antibodies most frequently linked to the condition.

research Drug-Induced Alopecia Areata: A Systematic Review

3 citations , May 2023 in “Journal of the American Academy of Dermatology”

This study found that drug-induced alopecia areata was most commonly associated with TNF-alpha inhibitors and dupilumab, with most cases improving after discontinuing the medication.

research Androgenetic Alopecia: Therapy Update

May 2023 in “Drugs”

This comprehensive review analyzes androgenetic alopecia treatments, discussing the mechanisms, costs, efficacy, and safety of FDA-approved drugs like minoxidil and finasteride, as well as newer non-FDA-approved options that have shown effectiveness across various studies.

research Recent Advances in Understanding of the Etiopathogenesis, Diagnosis, and Management of Hair Loss Diseases

May 2023 in “Journal of Clinical Medicine”

This review article reports recent advancements in understanding, diagnosing, and treating various hair loss conditions, like androgenetic alopecia and alopecia areata, including their genetic factors and new therapeutic options, while also examining the impact of COVID-19 on hair loss.

research Prevention and Treatment of Chemotherapy-Induced Alopecia: What Is Available and What Is Coming?

4 citations , March 2023 in “Current Oncology”

This study reviews current methods and emerging approaches to prevent and treat chemotherapy-induced hair loss, reporting that evidence-based research is needed to validate effective strategies, which could enhance cancer patients’ quality of life and treatment compliance.

research Low-Dose Oral Minoxidil Improves Hair Density in Traction Alopecia

February 2023 in “Journal of The American Academy of Dermatology”

This publication discusses the use of low-dose oral minoxidil for treating traction alopecia but reports no new clinical outcomes; further research on its efficacy and safety is needed.

research The Burden of Alopecia Areata: A Scoping Review Focusing on Quality of Life, Mental Health, and Work Productivity

10 citations , January 2023 in “Journal of the European Academy of Dermatology and Venereology”

This review highlights the significant negative impact of alopecia areata on quality of life, mental health, and work, calling for individualized approaches and effective treatments to mitigate these effects.

research Minoxidil: A Comprehensive Review

16 citations , June 2021 in “Journal of Dermatological Treatment”

This study reported that while topical minoxidil exhibits hair regrowth in androgenetic alopecia, oral minoxidil 5 mg/day was more effective than topical forms after six months, with low doses also potentially effective for women and other hair loss types.

research Telogen Effluvium: A Review of the Science and Current Obstacles

23 citations , January 2021 in “Journal of Dermatological Science”

This review describes the diagnosis and management challenges of telogen effluvium, a type of hair loss triggered by physiological stress, and summarizes current understanding of its mechanisms and treatments while recommending future research directions.

The Efficacy and Safety of Finasteride Combined with Topical Minoxidil for Androgenetic Alopecia: A Systematic Review and Meta-Analysis

research The Efficacy and Safety of Finasteride Combined with Topical Minoxidil for Androgenetic Alopecia: A Systematic Review and Meta-Analysis

8 citations , March 2020 in “Aesthetic Plastic Surgery”

Finasteride and minoxidil together safely and effectively increase hair growth and density for androgenetic alopecia.

research Management of Hair Loss Associated with Endocrine Therapy in Patients with Breast Cancer: An Overview

7 citations , May 2016 in “SpringerPlus”

This review suggests that treating endocrine therapy-induced hair loss in breast cancer patients with topical 5-alpha reductase inhibitors and supplements like Vitamin C and omega-3 fatty acids may be effective, but further studies are needed.

research Selected Disorders of Skin Appendages: Acne, Alopecia, Hyperhidrosis

51 citations , September 2015 in “Medical Clinics of North America”

This review discusses common skin appendage diseases, including their pathophysiology and treatments, but does not report new results.

research Evaluation and Diagnosis of the Hair Loss Patient

86 citations , August 2014 in “Journal of The American Academy of Dermatology”

This article discusses the history taking and clinical examination process for diagnosing alopecia and outlines a diagnostic approach, noting that it reports no new clinical results.

research Estrogens and Aging Skin

150 citations , April 2013 in “Dermato-endocrinology”

This review discusses the effects of estrogen on skin aging and highlights potential therapies, but reports no new clinical findings.

research Pathobiology of Chemotherapy-Induced Hair Loss

218 citations , January 2013 in “The Lancet Oncology”

This review discusses the pathobiology of chemotherapy-induced alopecia and highlights challenges in managing it, reporting no new clinical results and emphasizing the need for well-designed preclinical models to develop effective treatments.

research A Descriptive Study of Alopecia Patterns and Their Relation to Thyroid Dysfunction

22 citations , January 2013 in “International Journal of Trichology”

Hair loss is often linked to thyroid problems, especially in women and older people, and screening for thyroid issues is advised for those with hair loss.

research Managing Hair Loss in Midlife Women

17 citations , November 2012 in “Maturitas”

This review discusses the management of hair loss in midlife women, focusing on female pattern hair loss, hair shaft alterations from hair care, and telogen effluvium, and reports no new research findings.

research Chemotherapy-Induced Alopecia

44 citations , November 2010 in “Current Opinion in Supportive and Palliative Care”

This review discusses interventions for chemotherapy-induced hair loss and reports no new clinical results; scalp cooling and nutritional support are considered potential strategies but not yet substantiated.

research Alopecia Areata Update

391 citations , January 2010 in “Journal of The American Academy of Dermatology”

This article reviews the clinical presentation and histopathologic features of alopecia areata and proposes a hypothesis for its development, but it reports no new clinical results.

Thyroid Hormones Directly Alter Human Hair Follicle Functions: Anagen Prolongation and Stimulation of Both Hair Matrix Keratinocyte Proliferation and Hair Pigmentation

research Thyroid Hormones Directly Alter Human Hair Follicle Functions: Anagen Prolongation and Stimulation of Both Hair Matrix Keratinocyte Proliferation and Hair Pigmentation

115 citations , August 2008 in “The Journal of Clinical Endocrinology & Metabolism”

In this study, T3 and T4 were found to directly influence human hair follicles in vitro, enhancing keratinocyte proliferation, prolonging the hair growth phase, and affecting pigmentation.

research Drug-Induced Hair Disorders

40 citations , August 2006 in “Current Drug Safety”

This article reviews how various drugs may cause hair loss, stimulate growth, or alter hair characteristics, but reports no new clinical results; drug-induced hair loss is typically reversible.

research Molecular Mechanisms of Androgenetic Alopecia

229 citations , August 2002 in “Experimental Gerontology”

This paper discusses key mechanisms of androgen metabolism in androgenetic alopecia and reports the effectiveness of treatments like oral finasteride and topical minoxidil, highlighting the limited success rate due to factors like follicular inflammation.

research The Biology of Hair Follicles

1113 citations , August 1999 in “The New England Journal of Medicine”

This article discusses the biologic and psychosocial significance of hair, the current limitations in hair growth drugs, and anticipates future therapies based on advancing hair follicle research.

research Psychological Effects of Androgenetic Alopecia on Women: Comparisons with Balding Men and Female Control Subjects

222 citations , October 1993 in “Journal of The American Academy of Dermatology”

This study found that androgenetic alopecia causes significant psychological distress, particularly in women, who exhibit a more negative body image and less adaptive functioning compared to controls.